<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">05105</article-id><article-id pub-id-type="doi">10.7554/eLife.05105</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>A highly-tunable dopaminergic oscillator generates ultradian rhythms of behavioral arousal</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-19531"><name><surname>Blum</surname><given-names>Ian D</given-names></name><aff><institution content-type="dept">Department of Psychiatry</institution>, <institution>McGill University</institution>, <addr-line><named-content content-type="city">Montreal</named-content></addr-line>, <country>Canada</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-20249"><name><surname>Zhu</surname><given-names>Lei</given-names></name><aff><institution content-type="dept">Department of Psychiatry</institution>, <institution>McGill University</institution>, <addr-line><named-content content-type="city">Montreal</named-content></addr-line>, <country>Canada</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-20250"><name><surname>Moquin</surname><given-names>Luc</given-names></name><aff><institution>Douglas Mental Health University Institute</institution>, <addr-line><named-content content-type="city">Montreal</named-content></addr-line>, <country>Canada</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-20251"><name><surname>Kokoeva</surname><given-names>Maia V</given-names></name><aff><institution content-type="dept">Department of Medicine</institution>, <institution>McGill University</institution>, <addr-line><named-content content-type="city">Montreal</named-content></addr-line>, <country>Canada</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-20252"><name><surname>Gratton</surname><given-names>Alain</given-names></name><aff><institution content-type="dept">Department of Psychiatry</institution>, <institution>McGill University</institution>, <addr-line><named-content content-type="city">Montreal</named-content></addr-line>, <country>Canada</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-20253"><name><surname>Giros</surname><given-names>Bruno</given-names></name><aff><institution content-type="dept">Department of Psychiatry</institution>, <institution>McGill University</institution>, <addr-line><named-content content-type="city">Montreal</named-content></addr-line>, <country>Canada</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-20248"><name><surname>Storch</surname><given-names>Kai-Florian</given-names></name><aff><institution content-type="dept">Department of Psychiatry</institution>, <institution>McGill University</institution>, <addr-line><named-content content-type="city">Montreal</named-content></addr-line>, <country>Canada</country><email>florian.storch@mcgill.ca</email></aff><xref ref-type="fn" rid="conf1"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1155"><name><surname>Palmiter</surname><given-names>Richard D</given-names></name><role>Reviewing editor</role><aff><institution>Howard Hughes Medical Institute, University of Washington</institution>, <country>United States</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>29</day><month>12</month><year>2014</year></pub-date><volume>3</volume><elocation-id>e05105</elocation-id><supplementary-material><ext-link xlink:href="elife-05105-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>10</day><month>10</month><year>2014</year></date><date date-type="accepted"><day>28</day><month>12</month><year>2014</year></date></history><permissions><copyright-statement>Â© 2014, Blum et al</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>Blum et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>Ultradian (~4 h) rhythms in locomotor activity that do not depend on the master circadian pacemaker in the suprachiasmatic nucleus have been observed across mammalian species, however, the underlying mechanisms driving these rhythms are unknown. We show that disruption of the dopamine transporter gene lengthens the period of ultradian locomotor rhythms in mice. Period lengthening also results from chemogenetic activation of midbrain dopamine neurons and psychostimulant treatment, while the antipsychotic haloperidol has the opposite effect. We further reveal that striatal dopamine levels fluctuate in synchrony with ultradian activity cycles and that dopaminergic tone strongly predicts ultradian period. Our data indicate that an arousal regulating, dopaminergic ultradian oscillator (DUO) operates in the mammalian brain, which normally cycles in harmony with the circadian clock, but can desynchronize when dopamine tone is elevated, thereby producing aberrant patterns of arousal which are strikingly similar to perturbed sleep-wake cycles comorbid with psychopathology.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All experimental procedures were performed in accordance with the Canadian Council on Animal Care guidelines and approved by the McGill University Animal Care Committee (animal use protocol #2010-5945).</p></fn></fn-group></back></article>